Gefitero 250 mg is a pharmaceutical tablet containing Gefitinib, an epidermal growth factor receptor (EGFR) inhibitor. It is primarily used in the treatment of non-small cell lung cancer (NSCLC), particularly in patients with specific EGFR mutations. Gefitinib works by blocking the activity of EGFR, a protein that promotes the growth and division of cancer cells. By inhibiting this protein, Gefitero helps to slow down or stop the proliferation of cancer cells, thereby managing the progression of the disease. This targeted therapy is especially beneficial for patients who have tumors with activating mutations in the EGFR gene, leading to improved response rates and progression-free survival compared to traditional chemotherapy. Gefitero 250 mg is manufactured by Hetero Healthcare Ltd, a reputable pharmaceutical company known for producing high-quality medications.Benefits of Gefitero 250 mg:
- Targeted Therapy: Specifically inhibits EGFR, leading to effective management of NSCLC in patients with EGFR mutations.
- Oral Administration: Convenient tablet form allows for easy oral intake, improving patient compliance.
- Improved Quality of Life: Offers a treatment option with a manageable side effect profile compared to traditional chemotherapy.
- Proven Efficacy: Clinical studies have demonstrated its effectiveness in controlling tumor growth and extending progression-free survival.
- Manufactured by Hetero Healthcare Ltd: Ensures adherence to stringent quality control measures, providing a reliable and safe medication.
Specification/Additional Details:
- Strength: 250 mg
- Packaging Type: Blister strip
- Packaging Size: 10 tablets per strip
- Brand: Gefitero
- Manufactured By: Hetero Healthcare Ltd
- Country of Origin: India
Reviews
There are no reviews yet.